Atlas Trials

Dyskinesia

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Dyskinesia

RecordFirmDate
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy (NCT05206513)Neurocrine Biosciences2022-04-15
A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients (NCT02439125)Amarantus BioScience Holdings, Inc.2015-05-01
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia (NCT02274766)Adamas Pharmaceuticals, Inc.2014-10-01
Open-Label Safety Study of ADS-5102 in PD Patients With LID (NCT02202551)Adamas Pharmaceuticals, Inc.2014-07-01
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) (NCT02136914)Adamas Pharmaceuticals, Inc.2014-05-01
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients (NCT01767129)Avanir Pharmaceuticals2013-10-16
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) (NCT01397422)Adamas Pharmaceuticals, Inc.2011-07-01
Famotidine for Levodopa-induced Dyskinesia in PD (NCT01937078)University Health Network, Toronto2011-04-01
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia (NCT00105521)EMD Serono2004-09-30
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia (NCT00105508)EMD Serono2004-09-30
Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia (NCT00114595)University of Stellenbosch2003-04-01
Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia (NCT00314288)EMD Serono2002-07-01

Track Dyskinesia automatically

Every clearance here is in the API, with alerts when new ones post.